Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Jorge Del Toro-Cervera"'
Autor:
Alejandra García-García, Pablo Demelo-Rodríguez, Lucia Ordieres-Ortega, Eva Cervilla-Muñoz, Irene García-Fernández-Bravo, Maria Dolores Pulfer, Ana López-Aparicio, Francisco Galeano-Valle, Jorge del Toro-Cervera
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-9 (2019)
Background: There is limited evidence on the etiology and outcomes of renal infarction. A provoking factor is identified only in one- to two-thirds of patients. Methods: This is a retrospective observational study. The clinical characteristics and ou
Externí odkaz:
https://doaj.org/article/46d57953414f4e409b651b8f3f60241e
Autor:
Crhistian-Mario Oblitas, Francisco Galeano-Valle, Laura Vela-De La Cruz, Jorge Del Toro-Cervera, Pablo Demelo-Rodríguez
Publikováno v:
Drug Target Insights, Vol 13 (2019)
A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain. Com
Externí odkaz:
https://doaj.org/article/a2b6c787456f45cc8a6ff6b1597cd312
Autor:
Crhistian-Mario Oblitas, Francisco Galeano-Valle, Laura Vela-De La Cruz, Jorge Del Toro-Cervera, Pablo Demelo-Rodríguez
Publikováno v:
Drug Target Insights, Vol 13, Iss 1 (2019)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/4017791549ac44c09c60d22d65a723df
Autor:
Neera Toledo-Samaniego, Crhistian Mario Oblitas, Eduardo Peñaloza-Martínez, Jorge del-Toro-Cervera, Luis Antonio Alvarez-Sala-Walther, Pablo Demelo-Rodríguez, Francisco Galeano-Valle
Publikováno v:
Journal of Thrombosis and Thrombolysis. 54:162-171
Autor:
Zichen Ji, Francisco Galeano-Valle, Javier de Miguel‐Díez, Lucía Ordieres-Ortega, Jorge del Toro-Cervera, Pablo Demelo-Rodríguez, Luis Álvarez-Sala-Walther
Publikováno v:
European Journal of Haematology
Introduction COVID‐19 predisposes patients to a higher risk of venous thromboembolism (VTE), although the extent of these implications is unclear and the risk of bleeding has been poorly evaluated. To date, no studies have reported long‐term outc
Autor:
Ángeles Fidalgo, Jorge Del-Toro-Cervera, Juan Francisco Sánchez Muñoz-Torrero, Francisco Galeano-Valle, Manuel Monreal, Patricia Sigüenza, Riete Investigators, Ángel Sampériz, Jorge Lima, Pablo Demelo-Rodríguez, Antonella Tufano
Publikováno v:
Thrombosis Research. 194:178-182
Background: The time in therapeutic range (TTR) of patients with venous thromboembolism (VTE) treated with vitamin K antagonists (VKA) is usually below recommended, leading to higher frequency of vascular events, bleeding and mortality. The SAMe-TT2R
Autor:
Jorge Del-Toro-Cervera, Enrique Calleja-Cartón, Eva Cervilla-Muñoz, Pablo Demelo-Rodríguez, Francisco Galeano-Valle
Publikováno v:
ERJ Open Research, Vol 6, Iss 3 (2020)
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research
article-version (VoR) Version of Record
Pulmonary artery sarcoma (PAS) is a rare tumour that originates from the intimal layer of the pulmonary trunk and pulmonary arteries. Diagnosis of PAS is challenging, since it can be difficult to distinguish from a pulmonary embolism. The evidence re
Autor:
Eduardo Fernández-Carracedo, José María Bellón-Cano, Francisco Galeano-Valle, Almudena Marcelo-Ayala, Pablo Demelo-Rodríguez, Jorge Del-Toro-Cervera, Luis Álvarez-Sala-Walther, Alicia Cuenca-Zarzuela, Marina Gómez-Morales
Publikováno v:
Medicina Clínica (English Edition). 155:51-56
Aims The association of on-admission CRP and early adverse outcomes in acute venous thromboembolism (VTE) has not been investigated. We hypothesized that increased on-admission CRP levels would correlate with adverse outcomes in patients with acute V
Autor:
Crhistian Mario Oblitas, Raquel Ojeda-García, Mikel Echenagusía-Boyra, Francisco Galeano-Valle, Andrea Palacios-Bermejo, Arturo Álvarez-Luque, Pablo Demelo-Rodríguez, Alejandra García-García, Jorge Del-Toro-Cervera
Publikováno v:
Thrombosis Research. 196:305-307
Introduction Inferior vena cava agenesis (IVCA) is a rare and underdiagnosed congenital anomaly that predisposes to deep vein thrombosis (DVT). Optimal duration of anticoagulant treatment in these patients is not well established. Method Observationa
Publikováno v:
Revista Clínica Española. 220:210-212